Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

WSE/BIO stock hub

WSE/BIO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/BIOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

358.9M

Warsaw Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

WSE/BIO

In the news

Latest news · WSE/BIO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E105.8

P25 n/aP50 n/aP75 n/a

ROE0.6

P25 n/aP50 n/aP75 n/a

ROIC0.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/BIO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

218

Groups with data

Currency

PLN

Showing 218 of 218 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	364
Employees Change	5%
Employees Change Percent	1.39
Enterprise value	PLN 407.8M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology
Isin	PLBIOTN00029
Last refreshed	2026-05-10
Market cap	PLN 358.9M
Price	PLN 4.18
Price currency	PLN
Rev Per Employee	778,294.77x
Sector	Healthcare
Sic	2834
Symbol	wse/BIO
Website	https://www.bioton.pl

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.95%
EV Earnings	120.19x
EV/EBIT	30.62x
EV/EBITDA	7.88x
EV/FCF	42.68x
EV/Sales	1.44x
FCF yield	2.66%
P/B ratio	0.6x
P/E ratio	105.82x
P/S ratio	1.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.71%
EBITDA Margin	18.33%
FCF margin	3.38%
Gross margin	32.49%
Gross Profit	PLN 91.8M
Gross Profit Growth	41.57%
Gross Profit Growth Q	18.24%
Gross Profit Growth3 Y	-1.4%
Gross Profit Growth5 Y	-1.76%
Net Income	PLN 3.4M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	33.66%
Net Income Growth5 Y	-36.9%
Pretax Margin	2.77%
Profit Margin	1.2%
Profit Per Employee	PLN 9,347
Profitable Years	1
ROA	1.07
Roa5y	0.63
ROCE	2.01
ROE	0.57
Roe5y	-0.19
ROIC	0.9
Roic5y	0.31

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.13%
Cagr15y	-8.56%
Cagr1y	10.01%
Cagr20y	-18.26%
Cagr3y	4.81%
Cagr5y	-4.99%
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	33.64
EPS Growth5 Y	-36.91
FCF Growth	-62%
FCF Growth3 Y	-28.83%
FCF Growth5 Y	-23.83%
OCF Growth	-37.73%
OCF Growth Q	-79.82%
OCF Growth10 Y	-0.6%
OCF Growth3 Y	-26.11%
OCF Growth5 Y	-11.62%
Revenue Growth	35.98x
Revenue Growth Q	-17.11x
Revenue Growth Years	2x
Revenue Growth3 Y	6.61x
Revenue Growth5 Y	4.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 0.36
Assets	PLN 764.6M
Cash	PLN 8.3M
Current Assets	PLN 145.1M
Current Liabilities	PLN 102.9M
Debt	PLN 57.2M
Debt EBITDA	PLN 1.1
Debt Equity	PLN 0.1
Debt FCF	PLN 5.98
Equity	PLN 594M
Interest Coverage	2.63
Liabilities	PLN 170.6M
Long Term Assets	PLN 619.5M
Long Term Liabilities	PLN 67.7M
Net Cash	PLN -48.9M
Net Cash By Market Cap	PLN -13.62
Net Debt EBITDA	PLN 0.94
Net Debt Equity	PLN 0.08
Net Debt FCF	PLN 5.12
Tangible Book Value	PLN 378.3M
Tangible Book Value Per Share	PLN 4.41
WACC	4.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.41
Inventory Turnover	1.89
Net Working Capital	PLN 70.2M
Quick ratio	0.49
Working Capital	PLN 42.2M
Working Capital Turnover	PLN 10.65

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-57.17%
1Y total return	10%
200-day SMA	4.18
3Y total return	15.15%
50-day SMA	4.2
50-day SMA vs 200-day SMA	50over200
5Y total return	-22.59%
All Time High	768
All Time High Change	-99.46%
All Time High Date	2006-05-17
All Time Low	2
All Time Low Change	109%
All Time Low Date	2013-08-20
ATR	0.09
Beta	0.16
Beta1y	0.26
Beta2y	0.16
Ch YTD	8.29
High	4.26
High52	4.7
High52 Date	2025-07-30
High52ch	-11.06%
Low	4.14
Low52	3.65
Low52 Date	2025-12-23
Low52ch	14.52%
Ma50ch	-0.36%
Price vs 200-day SMA	0.07%
RSI	49.63
RSI Monthly	54.37
RSI Weekly	52.15
Sharpe ratio	0.37x
Sortino ratio	0.87
Tr YTD	8.29
Tr15y	-73.88%
Tr1m	-1.88%
Tr1w	1.21%
Tr3m	6.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN 13.3M
Operating Income Growth Q	19.73
Operating Income Growth3 Y	-18
Operating Income Growth5 Y	-24.78
Operating margin	4.71

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	43,091,578%
Net Borrowing	-1,012,000
Shares Institutions	0.37%
Shares Out	85,864,200
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN 9.6M
Average Volume	15,654.95x
Bv Per Share	6.92
CAPEX	PLN -13.1M
Ch10y	-57.17
Ch15y	-73.88
Ch1m	-1.88
Ch1w	1.21
Ch1y	10
Ch20y	-99.33
Ch3m	6.36
Ch3y	15.15
Ch5y	-22.59
Ch6m	0.24
Change	-0.48%
Change From Open	0.97
Close	4.2
Days Gap	-1.43
Depreciation Amortization	38,465,000
Dollar Volume	66,700.3
Earnings Date	2026-04-29
EBIT	PLN 13.3M
EBITDA	PLN 51.8M
EPS	PLN 0.04
F Score	7
FCF	PLN 9.6M
FCF EV Yield	2.34x
FCF Per Share	PLN 0.11
Financing CF	-8,291,000
Fiscal Year End	December
Founded	1,989
Graham Number	2.47951
Graham Upside	-40.68
Income Tax	PLN 4.4M
Investing CF	-13,009,000
Is Primary Listing	1
Last Earnings Date	2026-04-29
Last Report Date	2025-12-31
Last Split Date	2014-01-14
Last Split Type	Reverse
Lynch Fair Value	PLN 0.2
Lynch Upside	-95.28
Ma150	4.13
Ma150ch	1.16%
Ma20	4.18
Ma20ch	0.05%
Net CF	1,320,000
Next Earnings Date	2026-05-29
Open	4.14
P FCF Ratio	37.57
P OCF Ratio	15.87
Position In Range	34.78
Ppne	292,307,000
Price Date	2026-05-08
Price EBITDA	PLN 6.93
Ptbv Ratio	0.95
Relative Volume	1.04x
Revenue	282,521,000x
Tax By Revenue	1.57x
Tax Rate	56.67%
Tr20y	-98.23%
Tr6m	0.24%
Volume	15,957
Z Score	-0.3

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/BIO pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/BIO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/BIO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

WSE/BIO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.6

Neutral momentum band

Price vs 200-day MA

+0.1%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/BIO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/BIO stock rating?

wse/BIO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/BIO analysis?

The full report lives at /stocks/wse/BIO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/BIO?

The latest report frames wse/BIO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/BIO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.